Browsing: session 6

The panel discussed various aspects related to the use of next-generation sequencing (NGS) and flow cytometry for minimal residual disease…

This in-depth discussion among experts explores various facets of leukemia management. The conversation spans topics including challenges in clonotypable patients,…